Trident Texofab [TTFL] vs KPR Mill [KPRMILL] Detailed Stock Comparison
Trident Texofab
BSE
Loading...
KPR Mill
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Trident Texofab wins in 5 metrics, KPR Mill wins in 13 metrics, with 0 ties. KPR Mill appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Trident Texofab | KPR Mill | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 103.29 | 42.17 | KPR Mill |
| Price-to-Book Ratio | 4.64 | 6.95 | Trident Texofab |
| Debt-to-Equity Ratio | 62.67 | 9.32 | KPR Mill |
| PEG Ratio | N/A | 30.75 | N/A |
| EV/EBITDA | 44.92 | 28.08 | KPR Mill |
| Profit Margin (TTM) | 2.06% | 12.60% | KPR Mill |
| Operating Margin (TTM) | 2.47% | 14.55% | KPR Mill |
| EBITDA Margin (TTM) | 2.47% | 14.55% | KPR Mill |
| Return on Equity | 7.91% | 16.30% | KPR Mill |
| Return on Assets (TTM) | 2.62% | 13.67% | KPR Mill |
| Free Cash Flow (TTM) | $-137.08M | $12.33B | KPR Mill |
| Dividend Yield | N/A | 0.40% | N/A |
| 1-Year Return | 384.01% | 10.03% | Trident Texofab |
| Price-to-Sales Ratio (TTM) | 2.64 | 5.31 | Trident Texofab |
| Enterprise Value | $2.46B | $353.95B | KPR Mill |
| EV/Revenue Ratio | 2.01 | 5.41 | Trident Texofab |
| Gross Profit Margin (TTM) | 14.02% | 17.36% | KPR Mill |
| Revenue per Share (TTM) | $116 | $191 | KPR Mill |
| Earnings per Share (Diluted) | $2.08 | $24.10 | KPR Mill |
| Beta (Stock Volatility) | -1.45 | 0.23 | Trident Texofab |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Trident Texofab vs KPR Mill Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Trident Texofab | 0.73% | 0.35% | -0.39% | 12.43% | 30.09% | 25.24% |
| KPR Mill | -3.11% | -7.72% | -18.58% | -17.16% | 10.61% | -0.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Trident Texofab | 384.01% | 79.12% | 414.00% | 397.34% | 397.34% | 397.34% |
| KPR Mill | 10.03% | 71.05% | 816.69% | 1,180.79% | 5,457.56% | 5,904.88% |
Performance & Financial Health Analysis: Trident Texofab vs KPR Mill
| Metric | TTFL | KPRMILL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹3.22B | ₹347.59B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 6,700 | 481,139 |
| 90 Day Avg. Volume | 18,958 | 579,480 |
| Last Close | ₹214.85 | ₹984.80 |
| 52 Week Range | ₹42.01 - ₹220.00 | ₹755.50 - ₹1,389.00 |
| % from 52W High | -2.34% | -29.10% |
| All-Time High | ₹220.00 (Jun 23, 2025) | ₹1,389.00 (May 05, 2025) |
| % from All-Time High | -2.34% | -29.10% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.27% | 0.10% |
| Quarterly Earnings Growth | 0.27% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.13% |
| Operating Margin (TTM) | 0.02% | 0.15% |
| Return on Equity (TTM) | 0.08% | 0.16% |
| Debt to Equity (MRQ) | 62.67 | 9.32 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹46.27 | ₹146.34 |
| Cash per Share (MRQ) | ₹3.09 | ₹16.94 |
| Operating Cash Flow (TTM) | ₹-137,076,992 | ₹11.06B |
| Levered Free Cash Flow (TTM) | ₹-188,124,000 | ₹8.15B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.40% |
| Last 12-Month Dividend | ₹0.00 | ₹5.00 |
Valuation & Enterprise Metrics Analysis: Trident Texofab vs KPR Mill
| Metric | TTFL | KPRMILL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 103.29 | 42.17 |
| Forward P/E | N/A | 30.75 |
| PEG Ratio | N/A | 30.75 |
| Price to Sales (TTM) | 2.64 | 5.31 |
| Price to Book (MRQ) | 4.64 | 6.95 |
| Market Capitalization | ||
| Market Capitalization | ₹3.22B | ₹347.59B |
| Enterprise Value | ₹2.46B | ₹353.95B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.01 | 5.41 |
| Enterprise to EBITDA | 44.92 | 28.08 |
| Risk & Other Metrics | ||
| Beta | -1.45 | 0.23 |
| Book Value per Share (MRQ) | ₹46.27 | ₹146.34 |
Financial Statements Comparison: Trident Texofab vs KPR Mill
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TTFL | KPRMILL |
|---|---|---|
| Revenue/Sales | ₹382.06M | ₹17.01B |
| Cost of Goods Sold | ₹328.49M | ₹14.06B |
| Gross Profit | ₹53.58M | ₹2.95B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹14.91M | ₹3.04B |
| EBITDA | ₹18.34M | ₹3.11B |
| Pre-Tax Income | ₹3.83M | ₹2.81B |
| Income Tax | ₹-1.27M | ₹761.80M |
| Net Income (Profit) | ₹5.10M | ₹2.05B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TTFL | KPRMILL |
|---|---|---|
| Cash & Equivalents | ₹1.09M | ₹1.15B |
| Total Current Assets | ₹737.44M | ₹33.26B |
| Total Current Liabilities | ₹407.50M | ₹7.75B |
| Long-Term Debt | ₹102.71M | ₹538.30M |
| Total Shareholders Equity | ₹472.39M | ₹50.02B |
| Retained Earnings | N/A | ₹46.56B |
| Property, Plant & Equipment | ₹200.87M | ₹2.67B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TTFL | KPRMILL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TTFL | KPRMILL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 6,700 | 481,139 |
| Average Daily Volume (90 Day) | 18,958 | 579,480 |
| Shares Outstanding | 13.56M | 341.81M |
| Float Shares | 5.51M | 110.93M |
| % Held by Insiders | 0.38% | 0.68% |
| % Held by Institutions | 0.00% | 0.22% |
Dividend Analysis & Yield Comparison: Trident Texofab vs KPR Mill
| Metric | TTFL | KPRMILL |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹5.00 |
| Last 12-Month Dividend Yield | N/A | 0.40% |
| 3-Year Avg Annual Dividend | ₹0.00 | ₹4.72 |
| 3-Year Avg Dividend Yield | N/A | 0.26% |
| 3-Year Total Dividends | ₹0.00 | ₹14.15 |
| Ex-Dividend Date | N/A | Jul 23, 2025 |